Drugs / STS01
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06402630 | Mar 2022 → Apr 2024 | alopecia areata | Soterios Ltd | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | STS-01 | “STS-01 is being developed to address the need for an effective, safe and convenient non-steroidal topical treatment for mild-moderate alopecia areata.” NCT06402630 ↗ |
| Route | Topical | “STS-01 topical cream applied to affected area of the head” NCT06402630 ↗ |